These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26165843)

  • 1. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
    Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
    J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice.
    Ji X; Nie C; Yao Y; Ma Y; Huang H; Hao C
    PeerJ; 2024; 12():e17106. PubMed ID: 38646478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A8 contributes to postoperative cognitive dysfunction in mice undergoing tibial fracture surgery by activating the TLR4/MyD88 pathway.
    Lu SM; Yu CJ; Liu YH; Dong HQ; Zhang X; Zhang SS; Hu LQ; Zhang F; Qian YN; Gui B
    Brain Behav Immun; 2015 Feb; 44():221-34. PubMed ID: 25449673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
    Ye K; Chen QW; Sun YF; Lin JA; Xu JH
    J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
    Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
    J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions.
    Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M
    J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
    Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
    mBio; 2012; 3(4):. PubMed ID: 22872782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
    Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
    Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
    Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.
    Kwon CH; Moon HJ; Park HJ; Choi JH; Park DY
    Mol Cells; 2013 Mar; 35(3):226-34. PubMed ID: 23456298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.
    Hiratsuka S; Watanabe A; Sakurai Y; Akashi-Takamura S; Ishibashi S; Miyake K; Shibuya M; Akira S; Aburatani H; Maru Y
    Nat Cell Biol; 2008 Nov; 10(11):1349-55. PubMed ID: 18820689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans induces the expression of chemokines MCP-1, MIP-1α, and IP-10 via similar but distinct signaling pathways in murine macrophages.
    Park OJ; Cho MK; Yun CH; Han SH
    Immunobiology; 2015 Sep; 220(9):1067-74. PubMed ID: 26003840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.
    Shimamoto A; Chong AJ; Yada M; Shomura S; Takayama H; Fleisig AJ; Agnew ML; Hampton CR; Rothnie CL; Spring DJ; Pohlman TH; Shimpo H; Verrier ED
    Circulation; 2006 Jul; 114(1 Suppl):I270-4. PubMed ID: 16820585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
    Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.